Covid-19 Vaccine: Russia releases first batch of Sputnik V for public

Published On 2020-09-08 07:37 GMT   |   Update On 2020-09-08 07:37 GMT

Moscow: The first batch of the Sputnik V vaccine against Covid-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs."The first batch of the 'Gam-Covid-Vac' [Sputnik V] vaccine...

Login or Register to read the full article

Moscow: The first batch of the Sputnik V vaccine against Covid-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs.

"The first batch of the 'Gam-Covid-Vac' [Sputnik V] vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor [medical device regulator] and has been released into civil circulation," the ministry said in a statement.
The Russian health ministry registered the first vaccine against Covid-19, named Sputnik V, on August 11.
Moscow Mayor Sergey Sobyanin expressed hope on Sunday that the majority of the Russian capital's residents would be vaccinated against the coronavirus within several months.
According to the health ministry, the delivery of the first batches of the Russian vaccine to the country's regions is planned in the nearest future.




Tags:    
Article Source : ANI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News